Before GLP-1 use, the majority of participants reported being non-smokers (56.4%), which remained unchanged after GLP-1 use
GLP-1 receptor agonists have shown strong efficacy in promoting weight loss and improving glycemic control, making them a preferred choice for patients with obesity, type 2 diabetes, and cardiovascular risk factors
Clinical data suggest meaningful body-weight reductions over time when Semaglutide is combined with consistent dietary, activity, and behavioral changes, which Better Med Spa supports through ongoing follow-up and coaching
Focus on leafy greens, broccoli, cauliflower, bell peppers, zucchini, and tomatoes